The earlier patients diagnosed with type 2 diabetes started taking metformin, the longer the drug remained effective, says a new study, published in Diabetes Care. The study reported by EurekAlert used electronic health records to follow nearly 1,800 people with diabetes in Kaiser Permanente’s health plan in Washington and...

On Friday  over its diabetes drug Avandia, charging a decade of false advertising and seeking compensation on behalf of patients and providers in California.   MercuryNews reports the county claims the drugmaker made billions of dollars on Avandia, which caused heart attacks and strokes. Although may personal-injury lawsuits against...

GlaxoSmithKline (GSK) responded to the recently released Senate Committee on Finance report regarding Avandia. GSK said it rejects any allegations of concealing safety information or acting inappropriately on behalf of patients.  GSK also said it disagrees with the Committee’s decision to publish a Staff Report with the errors...

According to a new study, published in the journal Maturitas, by a team of researchers at Warwick Medical School, middle aged and elderly people with high levels of vitamin D could reduce their chances of developing heart disease or diabetes by 43%. The researchers looked at 28 studies including 99,745 participants across a variety...

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will  advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin)  and metreleptin  (an...

The Food and Drug Administration (FDA) announced it would be reviewing data submitted in August 2009, from a large, long-term clinical study (RECORD study) on possible risks associated with the diabetes drug, Avandia (rosiglitazone). The FDA said it will complete its review of the data from the RECORD study, and will then present...

New York Times Report : Hundreds of people taking Avandia, a controversial diabetes medicine, needlessly suffer heart attacks and heart failure each month, according to confidential government reports that recommend the drug be removed from the market. The reports, obtained by The New York Times, say that if every diabetic now taking...

Using stem cells from a patient’s own body fat, scientists have been able to reverse symptoms of multiple sclerosis , reports Telegraph.  MS, an autoimmune disease, is caused by the destruction of myelin, a fatty protective sheath surrounding the body’s central nervous system.  These preliminary findings, based on three...

A new treatment for type 1 diabetes could be a step closer thanks to a EU grant of €10.9 million, according to a Media-Newswire press release. Two University of Bristol academics are part of a group of 14 leading researchers who have received the award.  Professor Polly Bingley and Dr Colin Dayan will collaborate with researchers from...

The Lancet published a study out of the University of Glasglow which examined the use of the cholesterol lowering drug statins, taken by millions, and incidence of diabetes.  Trials of statin therapy have had conflicting findings on the risk of development of diabetes in patients given statins. The researchers aimed to establish by a...